„Доставка на противотуморни лекарствени продукти за лечение на хематологични заболявания, за нуждите на УМБАЛ „Александровска“ ЕАД”
Free bulletin
Similar tenders – every morning in your inbox
A free bulletin with new tenders for this sector and region. No password, unsubscribe with one click.
Description by the buyer
The buyer's official text, in Bulgarian. Request the AI summary above to read it in English.
Доставка на противотуморни лекарствени продукти за лечение на хематологични заболявания, за нуждите на УМБАЛ „Александровска“ ЕАД, съгласно техническа спецификация. Спецификацията на лекарствените продукти е разделена на 68 обособени позиции. Място за изпълнение на обществената поръчка: Болнична аптека на УМБАЛ „Алексанровска“ ЕАД, гр. София, ул.“Св. Георги Софийски“ №1.
Срок за изпълнение на обществената поръчка: 12 месеца от датата на сключване на договора за възлагане изпълнението на обществената поръчка. Срок на доставка – не по-дълъг от 48 часа , а при спешност 24 часа от дата на подаване на заявката.
Към датата на доставката, остатъчният срок на годност трябва да бъде не по-малко от 40 % от обявения от производителя, а за биологичните лекарствени продукти не по-малък от 25 % от обявения от производителя. Към датата на доставката, остатъчният срок на годност трябва да бъде не по-малко от 40 % от обявения от производителя, а за биологичните лекарствени продукти не по-малък от 25 % от обявения от производителя.
Lots (68)
| № | Name | Estimated value |
|---|---|---|
| 1 | Acalabrutinib -film coated tablet -tabl.-100 mg | €1,292,042 |
| 2 | Anagrelide -capsule-caps.-0.5 mg | €46,385 |
| 3 | Avapritinib -Film-coated tablet-film-tabl-50 mg | €1,603,275 |
| 4 | Avapritinib -Film-coated tablet-film-tabl-100 mg | €1,603,297 |
| 5 | Zanubrutinib -Capsule, hard caps.-80 mg | €370,020 |
| 6 | Bortezomib -powder for solution for injection-fl.-3.5 mg | €19,557 |
| 7 | Bortezomib -Solution for injection -fl.-2.5 mg/ml - 1.4 ml | €19,173 |
| 8 | Bosutinib -film coated tablet-film-tabl-100 mg | €35,238 |
| 9 | Calcium folinate -solution for injection/infusion-fl.-10 mg/ml-10 ml | €107.73 |
| 10 | Calcium folinate -solution for injection-fl.-10 mg/ml-50 ml | €256.08 |
| 11 | Calcium folinate -solution for injection-fl.-10 mg/ml-100 ml | €256.21 |
| 12 | Carfilzomib -Powder for solution for infusion-fl.-10 mg | €53,181 |
| 13 | Carfilzomib -Powder for solution for infusion-fl.-30 mg | €319,083 |
| 14 | Ciclosporin -capsules, soft caps.-50 mg | €4,343 |
| 15 | Cisplatin -concentrate for solution for infusion-fl-1 mg/ml - 50 ml | €996 |
| 16 | Teclistamab -Solution for injection-fl-10mg/ml - 3ml | €3,394 |
| 17 | Teclistamab -Solution for injection-fl-90mg/ml - 1,7ml | €337,575 |
| 18 | Cytarabine -Concentrate for solution for injection/infusion-fl.-50 mg/ ml - 20 ml | €2,005 |
| 19 | Daratumumab -Solution for injection -fl. -1800 mg/15 ml | €1,725,941 |
| 20 | Darbepoetin alfa -Solution for injection shpr.-amp. -300 µg (500 µg/ml) - 0.6 ml | €298,659 |
| 21 | Elranatamab -Solution for injection -fl -40 mg/ml - 1.1 ml | €23,330 |
| 22 | Elranatamab -Solution for injection -fl -40 mg/ml - 1.9 ml | €785,789 |
| 23 | Doxorubicin -concentrate for solution for infusion -fl. -2 mg/ml - 25 ml | €2,840 |
| 24 | Epcoritamab -Solution for injection -fl. -48 mg (60 mg/ml - 0.8 ml) | €591,267 |
| 25 | Epirubicin -Solution for infusion fl. -2 mg/ml - 50 ml | €6,645 |
| 26 | Epirubicin -Concentrate for solution for injection/infusion -fl. -2 mg/ml- 25 ml | €5,538 |
| 27 | Etoposide -concentrate for solution for infusion - fl.-20 mg/ml-5 ml | €1,020 |
| 28 | Fedratinib -Capsule, hard -caps. -100 mg | €294,432 |
| 29 | Filgrastim -Solution for injection/infusion -pfs -30 MU (300 mcg/0,5 ml) | €9,576 |
| 30 | Gemcitabine -concentrate for solution for infusion -fl.-100 mg/ml - 10 ml | €2,908 |
| 31 | Gemcitabine -Concentrate for solution for infusion -fl. -40 mg/ml – 25 ml | €2,908 |
| 32 | Glofitamab -Concentrate for solution for infusion -fl. -2.5 mg/2.5 ml (1 mg/ml) | €3,100 |
| 33 | Glofitamab -Concentrate for solution for infusion -fl. -10 mg/10 ml (1 mg/ml) | €421,615 |
| 34 | Ibrutinib -Capsule, hard caps -140 mg | €975,572 |
| 35 | Idarubicin -powder for solution for infusion -fl. -10 mg | €229.50 |
| 36 | Idarubicin - powder for solution for infusion - fl.-5 mg | €91.80 |
| 37 | Imatinib -film coated tablet -caps.-100 mg | €3,105 |
| 38 | Immunoglobulins, normal human, for intravascular adm. -Solution for infusion-fl- 50 g/l - 5 ml | €4,600 |
| 39 | Immunoglobulins, normal human, for intravascular adm. -Solution for infusion-fl-100 mg/ml - 10 ml (1 g) | €80,713 |
| 40 | Immunoglobulins, normal human, for intravascular adm. -Solution for infusion-fl-100 mg/ml - 100 ml (10 g) | €112,998 |
| 41 | Isatuximab -Concentrate for solution for infusion – fl-20 mg/ml - 5 ml | €84,583 |
| 42 | Isatuximab -Concentrate for solution for infusion – fl-20 mg/ml - 25 ml | €253,752 |
| 43 | Lenalidomide -capsules, hard-caps.-10 mg | €65,968 |
| 44 | Lipegfilgrastim -solution for injection-pfs-6 mg/0.6 ml | €11,808 |
| 45 | Luspatercept -Powder for solution for injection-fl. -25 mg | €102,251 |
| 46 | Luspatercept -Powder for solution for injection -fl.-75 mg | €511,028 |
| 47 | Methotrexate -Concentrate for solution for infusion-fl.-100 mg/ml - 10 ml | €562.25 |
| 48 | Mosunetuzumab -Concentrate for solution for infusion-fl.-1 mg (1 mg/ml - 1 ml) | €1,885 |
| 49 | Mosunetuzumab- Concentrate for solution for infusion-fl.-30 mg (1 mg/ml - 30 ml) | €263,857 |
| 50 | Nelarabine -solution for infusion-fl.-5 mg/ml - 50 ml | €77,522 |
| 51 | Nivolumab -concentrate for solution for infusion-fl.-10 mg/ml - 10 ml | €185,957 |
| 52 | Nivolumab -concentrate for solution for infusion-fl.-10 mg/ml - 4 ml | €37,191 |
| 53 | Midostaurin -Capsule, soft -caps.-25 mg | €144,971 |
| 54 | Mogamulizumab -Concentrate for solution for infusion-fl-4 mg/ml - 5 ml | €114,932 |
| 55 | Pegfilgrastim -Solution for injection-pfs-10 mg/ml – 0.6 ml | €38,217 |
| 56 | Pomalidomide -capsules, hard -caps.-4 mg | €55,936 |
| 57 | Ponatinib -Film-coated tablet-tabl.-15 mg | €290,903 |
| 58 | Rituximab -Concentrate for solution for infusion -fl.-100 mg/10 ml | €11,982 |
| 59 | Rituximab -Concentrate for solution for infusion-fl.-500 mg/50 ml | €33,863 |
| 60 | Zanubrutinib -Capsule, hard-caps. -80 mg | €380,362 |
| 61 | Ivosidenib -Film-coated tablet -tabl.-250 mg | €180,092 |
| 62 | Tocilizumab -Concentrate for solution for infusion -fl. -20 mg/ml - 10 ml | €14,948 |
| 63 | Tocilizumab -Concentrate for solution for infusion -fl. -20 mg/ml - 20 ml | €29,895 |
| 64 | Talquetamab -Solution for injection -fl.- 2 mg/ml -1.5 ml | €1,208 |
| 65 | Talquetamab -Solution for injection -fl. -40 mg/ml - 1 ml | €214,811 |
| 66 | Mycophenolic acid -Capsule, hard -caps.-250 mg | €850.50 |
| 67 | Tacrolimus -Prolonged-release capsule, hard -caps. -1 mg | €593.33 |
| 68 | Tacrolimus -Prolonged-release capsule, hard -caps.-3 mg | €958.18 |
Awarded contracts
| Contractor | Date | Value |
|---|---|---|
|
Medeks OOD
LOT-0001 |
21 Sep 2026 | €468,476 |
|
Fyoniks Farma EOOD
LOT-0001 |
15 Sep 2026 | €5,117,949 |
|
Alta Farmasyutikals OOD
LOT-0001 |
14 Sep 2026 | €314,360 |
|
Sofarma Treyding AD
LOT-0001 |
14 Sep 2026 | €5,521,384 |
|
Danson Treyding OOD
LOT-0001 |
11 Sep 2026 | €804,846 |
|
Pro Farmatsia EOOD
LOT-0001 |
8 Sep 2026 | €46,386 |
Documents (3)
- Проект на договор.pdf
- Техническа спецификация.pdf
- Документация.pdf
The documents are downloaded from the official source. Open in CAIS EOP